tetradecanoylphorbol acetate has been researched along with 6-bromoindirubin-3'-oxime in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
Chen, CL; Chen, SH; Choi, PC; Hsieh, CY; Huang, WC; Lin, CF; Lin, YS; Tsai, CC; Tseng, PC; Wong, TW | 1 |
2 other study(ies) available for tetradecanoylphorbol acetate and 6-bromoindirubin-3'-oxime
Article | Year |
---|---|
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Inhibiting glycogen synthase kinase-3 decreases 12-O-tetradecanoylphorbol-13-acetate-induced interferon-γ-mediated skin inflammation.
Topics: Animals; Cell Line; Dermatitis; Glycogen Synthase Kinase 3; Humans; Indoles; Interferon gamma Receptor; Interferon-gamma; Mice; Mice, Inbred C57BL; Mice, Knockout; Oximes; Receptors, Interferon; Tetradecanoylphorbol Acetate | 2012 |